Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|11|6|543-548

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.6, 2011-07, pp. : 543-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1275-1285

Spandidos Publications

Access to resources Recommend Favorite

Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3177-3184

Spandidos Publications

Access to resources Recommend Favorite

Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes

By                                    

International Journal of Oncology, Vol. 40, Iss. 1, 2012-01 ,pp. : 63-70

Spandidos Publications

Access to resources Recommend Favorite

The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches

By Hu Chi-Tan   Wu Jia-Ru   Cheng Chuan-Chu   Wu Wen-Sheng  

Cancers, Vol. 9, Iss. 6, 2017-05 ,pp. : 58-58

MDPI

Access to resources Recommend Favorite

Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells

By            

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3361-3367

Spandidos Publications

Access to resources Recommend Favorite